AGM/EGM4 Aug 2026, 11:34 am
Marksans Pharma Ltd. Releases FY26 Annual Report and AGM Notice
AI Summary
Marksans Pharma Ltd. has filed its Annual Report for the Financial Year 2025-26, along with the notice for its 34th Annual General Meeting (AGM). The AGM is scheduled for Thursday, August 27, 2026, at 11:00 a.m. and will be conducted through electronic mode. Shareholders will have the opportunity to participate via e-voting, which opens on August 24, 2026, and closes on August 26, 2026. The report details the company's performance, strategy, financial statements, and ESG initiatives under the theme 'Resilient. Rising. Relentless.' The annual report is also available on the company's website.
Key Highlights
- Marksans Pharma releases FY25-26 Annual Report.
- 34th AGM scheduled for August 27, 2026, via electronic mode.
- E-voting facility available from August 24-26, 2026.
- Report covers financial statements, strategy, and ESG.
- Annual report accessible on the company website.
Price Impact
More from MARKSANS